Division of Pulmonology, Allergy and Critical Care Medicine, Department of Internal Medicine, Yongin Severance Hospital, Yonsei University College of Medicine, Yongin, Republic of Korea.
Department of Preventive Medicine, Seoul National University, College of Medicine, Seoul, Republic of Korea.
PLoS One. 2023 Dec 14;18(12):e0295556. doi: 10.1371/journal.pone.0295556. eCollection 2023.
Despite its significant impact on mortality, tuberculosis (TB)-diabetes mellitus (DM) co-prevalence has not been well-elucidated for the cause of death. We investigated the impact of DM on TB-related and non-TB-related deaths in patients with TB. This retrospective nationwide cohort study included patients diagnosed with TB between 2011 and 2017 in South Korea. We performed Fine and Gray regression model analyses to assess the mortality risk of DM classified by cause of death. Of 239,848 patients, 62,435 (26.0%) had DM, and 20,203 died during anti-TB treatment. Of all deaths, 47.9% (9,668) were caused by TB, and the remaining 52.1% (10,535) was attributed to various non-TB-related causes. The mortality rate was higher in the DM than in the non-DM groups in both men and women. DM was associated with a higher risk of TB-related (adjusted hazard ratio [aHR] 1.07, 95% confidence interval [CI] 1.01-1.13) and non-TB-related (aHR 1.21, 95% CI 1.15-1.27) deaths in men; however, only a higher risk of non-TB-related deaths (aHR 1.29, 95% CI 1.20-1.38) in women. Our findings indicate that DM is independently associated with a greater risk of death during anti-TB treatment among patients with TB for both TB-related and non-TB-related deaths.
尽管结核病(TB)-糖尿病(DM)共病对死亡率有重大影响,但DM 导致 TB 患者死亡的原因尚未得到充分阐明。我们调查了 DM 对 TB 相关和非 TB 相关死亡的影响。本回顾性全国队列研究纳入了 2011 年至 2017 年期间在韩国被诊断为 TB 的患者。我们使用 Fine 和 Gray 回归模型分析来评估按死因分类的 DM 的死亡风险。在 239848 名患者中,有 62435 名(26.0%)患有 DM,20203 名患者在抗 TB 治疗期间死亡。所有死亡中,47.9%(9668 人)由 TB 引起,其余 52.1%(10535 人)归因于各种非 TB 相关原因。在男性和女性中,DM 组的死亡率均高于非 DM 组。DM 与男性的 TB 相关(调整后的危害比[aHR]1.07,95%置信区间[CI]1.01-1.13)和非 TB 相关(aHR 1.21,95% CI 1.15-1.27)死亡风险增加相关;然而,仅在女性中与非 TB 相关的死亡风险增加相关(aHR 1.29,95% CI 1.20-1.38)。我们的研究结果表明,DM 与 TB 患者抗 TB 治疗期间的死亡风险增加相关,无论是 TB 相关还是非 TB 相关死亡。